Table 1.
ID | Sex | Genotype | Gene | Variant (aa)a | Expected gene inheritance | Family tested | OMIM morbid descriptionb |
---|---|---|---|---|---|---|---|
2012D09029 | M | Hemi | CASK | p.R584X | X‐linked | De novo | Mental retardation and microcephaly with pontine and cerebellar hypoplasia |
2008D06721 | F | Hetero | EEF1A2 | p.G70S | Dominant | De novo | Epileptic encephalopathy, early infantile, 33 |
EG1761 | F | Hetero | FARS2 | p.T156M | Recessive | Compound het | Combined oxidative phosphorylation deficiency 14 |
EG1761 | F | Hetero | FARS2 | c.905‐1G>A (splice‐acceptor) | Recessive | Compound het | Combined oxidative phosphorylation deficiency 14 |
EP2201 | F | Hetero | GNAO1 | p.G40R | Dominant | De novo | Epileptic encephalopathy, early infantile, 17 |
EP2822 | M | Hetero | GPHN | p.D422N | Recessive | Compound het | Molybdenum cofactor deficiency, complementation group c |
EP2822 | M | Hetero | GPHN | c.1315‐2A>G (splice‐acceptor) | Recessive | Compound het | Molybdenum cofactor deficiency, complementation group c |
EP1718 | M | Homo | GRIN1 | p.Q556X | Dominant | Inherited from het parents | Mental retardation, autosomal dominant 8 |
EP2797 | M | Hetero | GRIN1 | p.G827R | Dominant | De novo | Mental retardation, autosomal dominant 8 |
2012D06376 | Hetero | HNRNPU | pV604 fs | Dominant | De novo | Candidate | |
2010D12136 | M | Hemi | IQSEC2 | p.Y1129X | X‐linked | De novo | Mental retardation, x‐linked 1 |
EP1961 | F | Hetero | IQSEC2 | p.G771D | X‐linked | De novo | Mental retardation, x‐linked 1 |
2010D05815 | F | Hetero | KCNB1 | p.F416L | Dominant | De novo | Epileptic encephalopathy, early infantile, 26 |
KIEL20 | M | Hetero | KCNB1 | p.R312H | Dominant | De novo | Epileptic encephalopathy, early infantile, 26 |
2012D20026 | M | Hetero | KCNQ2 | p.Y363H | Dominant | De novo | Epileptic encephalopathy, early infantile, 7 |
KIEL42 | F | Hetero | KCNQ2 | p.R532W | Dominant | De novo | Epileptic encephalopathy, early infantile, 7 |
2009D12616 | F | Hetero | KCNT1 | p.R429C | Dominant | Not tested | Epileptic encephalopathy, early infantile, 14 |
EP2788 | F | Hetero | KCNT1 | p.R429H | Dominant | De novo | Epileptic encephalopathy, early infantile, 14 |
EP95 | M | Hetero | KCNT1 | p.R429C | Dominant | De novo | Epileptic encephalopathy, early infantile, 14 |
1011L | F | Homo | PNKP | p.A420 fs | Recessive | Inherited from het parents | Epileptic encephalopathy, early infantile, 10 |
395M | F | Homo | POLG | p.R1096C | Recessive | Inherited from het parents | Leigh syndrome |
EP1781 | F | Hetero | SCN1A | p.C968G | Dominant | De novo | Epileptic encephalopathy, early infantile, 6 |
EUR577 | F | Hetero | SCN1A | p.I1347T | Dominant | De novo | Epileptic encephalopathy, early infantile, 6 |
KIEL38 | M | Hetero | SCN1A | p.D702 fs | Dominant | De novo | Epileptic encephalopathy, early infantile, 6 |
EP1789 | F | Hetero | SCN2A | p.L1665F | Dominant | De novo | Epileptic encephalopathy, early infantile, 11 |
EP2104 | M | Hetero | SCN2A | p.Q1811E | Dominant | De novo | Epileptic encephalopathy, early infantile, 11 |
2010D14438 | F | Hetero | SLC13A5 | p.S427L | Recessive | Compound het | Epileptic encephalopathy, early infantile, 25 |
2010D14438 | F | Hetero | SLC13A5 | p.G219R | Recessive | Compound het | Epileptic encephalopathy, early infantile, 25 |
EP2821 | F | Homo | SLC25A22 | p.Q117R | Recessive | Inherited from het parents | Epileptic encephalopathy, early infantile, 3 |
EP2806 | F | Hetero | SPTAN1 | p.R2037W | Dominant | De novo | Epileptic encephalopathy, early infantile, 5 |
EP2514 | M | Hetero | STXBP1 | p.P480L | Dominant | De novo | Epileptic encephalopathy, early infantile, 4 |
2013D03222 | M | Double het | TBC1D24 | p.E153K | Recessive | Testing | Epileptic encephalopathy, early infantile, 16 |
2013D03222 | M | Double het | TBC1D24 | p.H336 fs | Recessive | Testing | Epileptic encephalopathy, early infantile, 16 |
2008D07479 | F | Hetero | WDR45 | p.E155X | X‐linked dominant | De novo | Neurodegeneration with brain iron accumulation 5; SENDA |
Compound heterozygotes are shaded in gray.
Complete notation with accession numbers can be found in the supplementary table.
Morbid description in OMIM. Only the most relevant phenotype is listed here.